Nodular histiocytic lymphoma:Factors influencing prognosis and implications for aggressive chemotherapy

作者: John H. Glick , Eleanor McFadden , William Costello , Ediz Ezdinli , Costan W. Berard

DOI: 10.1002/1097-0142(19820301)49:5<840::AID-CNCR2820490503>3.0.CO;2-9

关键词:

摘要: Twenty-five patients with Stage III and IV nodular histiocytic lymphoma (NH), entered on three different Eastern Cooperative Oncology Group protocols from 1972-78, were analyzed for response survival. A complete (CR) rate of 44% was observed, 40% partial responders (PR). Four the 11 CRs are continuing in their original remission. Median survival 52 months; PRs it 30 months. The six treated cyclophosphamide-prednisone had a median 18 months versus 51 19 more aggressive combination chemotherapy programs. No significant difference noted between those both diffuse histology pure pattern. 25 NH 47 is similar to group 101 mixed (NM) same ECOG during this time. This intermediate lymphocytic poorly differentiated subtype lymphoma. It suggests that histologies be programs designed achieve remission prolonged disease-free

参考文章(17)
CK Osborne, L Norton, RC Young, AJ Garvin, RM Simon, CW Berard, S Hubbard, VT Jr DeVita, Nodular histiocytic lymphoma: an aggressive nodular lymphoma with potential for prolonged disease-free survival Blood. ,vol. 56, pp. 98- 103 ,(1980) , 10.1182/BLOOD.V56.1.98.98
Stephen E. Jones, James J. Butler, Gerald E. Byrne, Charles A. Coltman, Thomas E. Moon, Histopathologic review of lymphoma cases from the southwest oncology group Cancer. ,vol. 39, pp. 1071- 1076 ,(1977) , 10.1002/1097-0142(197703)39:3<1071::AID-CNCR2820390310>3.0.CO;2-C
Stephen E. Jones, Petre N. Grozea, Earl N. Metz, Arthur Haut, Ronald L. Stephens, Francis S. Morrison, James J. Butler, Gerald E. Byrne, Thomas E. Moon, Richard Fisher, Constance L. Haskins, Charles A. Coltman, Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma.A southwest oncology group study Cancer. ,vol. 43, pp. 417- 425 ,(1979) , 10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25
Ediz Z. Ezdinli, William G. Costello, Murray N. Silverstein, Costan Berard, Robert J. Hartsock, Joseph E. Sokal, Moderate versus intensive chemotherapy of prognostically favorable non-Hodgkin's lymphoma a progress report Cancer. ,vol. 46, pp. 29- 33 ,(1980) , 10.1002/1097-0142(19800701)46:1<29::AID-CNCR2820460105>3.0.CO;2-1
Ediz Z. Ezdinli, William G. Costello, Fikri Icli, Raymond E. Lenhard, Gerhard J. Johnson, Murray Silverstein, Costan W. Berard, John M. Bennett, Paul P. Carbone, Nodular mixed lymphocytic‐histiocytic lymphoma (NM) response and survival Cancer. ,vol. 45, pp. 261- 267 ,(1980) , 10.1002/1097-0142(19800115)45:2<261::AID-CNCR2820450210>3.0.CO;2-W
Ediz Ezdinli, Stuart Pocock, C. W. Berard, C. William Aungst, Murray Silverstein, John Horton, John Bennett, Richard Bakemeier, Leo Stolbach, Charles Perlia, S. Fred Brunk, Raymond E. Lenhard, D. J. Klaassen, Paul Richter, Paul Carbone, Comparison of intensive versus moderate chemotherapy of lymphocytic lymphomas. A progress report Cancer. ,vol. 38, pp. 1060- 1068 ,(1976) , 10.1002/1097-0142(197609)38:3<1060::AID-CNCR2820380304>3.0.CO;2-V
Ediz Z. Ezdinli, William Costello, Raymond E. Lenhard, Richard Bakemeier, John M. Bennett, Costan W. Berard, Paul P. Carbone, Survival of nodular versus diffuse pattern lymphocytic poorly differentiated lymphoma. Cancer. ,vol. 41, pp. 1990- 1996 ,(1978) , 10.1002/1097-0142(197805)41:5<1990::AID-CNCR2820410545>3.0.CO;2-G